Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 December 2020 | Story Leonie Bolleurs | Photo Supplied
At the BJCP beer judging competition, Dr Errol Cason won Best of Show with his Belgian Saison. Here he is presenting at the AfricaBrew2020 Brewing conference.

Staff and students from the University of the Free State (UFS) once again proved their skills in beer homebrewing when they walked away with one first place and two second places at the 13th annual Anheuser-Busch Inbev (AB-Inbev) – formally South African Breweries (SAB) – intervarsity beer brewing and tasting competition, and the Beer Judging Certification Programme (BJCP) competition held at the AfricaBrew2020 Brewing conference. Both these events took place over the weekend of 27 and 28 November 2020.

Evil Twin Double and Three Sips German 

Competing in the AB-Inbev/SAB Intervarsity brewing and tasting competition, was a group of students from the UFS Department of Microbial, Biochemical and Food Biotechnology, consisting of Eduvan Bischoff (PhD student), Elzette van der Walt (MSc student), Culien van der Merwe (MSc student), Gunther Staats (MSc student), and Twyne Skein (MSc student). This team came second in both the Indian Pale Ale (IPA) category with their Evil Twin Double IPA and in the Lager category with their Three Sips German Pils. 

“This is an outstanding accomplishment. Congratulations also go to our fellow Free Stater’s at the Central University of Technology (CUT) for winning the India Pale Ale (IPA) category as well as best overall beer with their New England IPA,” commented Dr Errol Cason, Senior Lecturer in the UFS Department of Animal Science, also representing the liquid yeast company LiquidCulture Yeast.

According to Dr Cason, this SAB-sponsored competition sees students from local universities brew and enter beers for judging, and competing for prizes, including the coveted ‘Best of Show’ trophy. 

“This event also aims to promote beer culture along with responsible drinking, by hosting talks by industry experts where students can interact with commercial brewers, scientists, and marketers,” says Dr Cason. 

The event was hosted by South African Breweries (SAB) and CUT, through the Centre for Applied Food Sustainability and Biotechnology (CAFSaB), in association with the UFS. 

Although the event was moved online in 2020 due to the international pandemic, it did not mean that there was a decline in the quality of presentations, or in the beer entered by universities. – D r Errol Cason

Dr Cason explains that entrants are usually challenged to brew beers according to the 2015 Beer Judge Certification Programme (BJCP) guidelines in lager, IPA, winter warmer, and fruit beer categories. 

“This year included the African Premium Ale and Lockdown Brew categories as well, where teams were mostly left to invent and experiment on their own with a few rules, such as using only indigenous African ingredients or ingredients that were available in supermarkets during lockdown,” says Dr Cason. 

There is also an award for the best bottle dress (label). 

Dr Cason believes that although the event was moved online in 2020 due to the international pandemic, it did not mean that there was a decline in the quality of presentations, or in the beer entered by universities. 

Belgian Saison and Extra Special Bitter

He and Christopher Rothmann, who is busy with a PhD in Biotechnology at the UFS and is co-founder of the company LiquidCulture (LC) Yeast, attended and presented at the AfricaBrew2020 Brewing conference. AfricaBrew is an annual brewing conference specialising in workshops and demonstrations for home and professional brewers. 

Accompanying the conference is a BJCP beer judging competition where all home and professional brewers can enter beers. During this competition, Dr Cason won Best of Show with his Belgian Saison. Rothmann came second with his Extra Special Bitter.

Since LiquidCulture Yeast was found in 2018, this commercial venture has since spun out and are now providing liquid brewing yeast to the homebrewing and commercial brewing industry. Rothmann and Dr Cason are also founding members of the Kovsie Brewery (along with Dr Jan-G Vermeulen and Eduan Hellmuth), which is currently being constructed on the UFS Paradys Experimental Farm facility.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept